Omni 360 Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Omni 360 Wealth, Inc.
- $171 Billion
- Q1 2025
A detailed history of Omni 360 Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Omni 360 Wealth, Inc. holds 3,221 shares of BMRN stock, worth $199,895. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,221Holding current value
$199,895% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
644Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.2 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.13 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$915 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$806 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...